Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas

Diabetologia

Volumn 13, Issue 6, 1977, Pages 571-577

  Turner, R C ^a,b   Heding, L G ^a,b  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b Novo Research Institute   (Denmark)

Author keywords

C peptide; insulin; Insulinoma; malignant insulinoma; proinsulin

Indexed keywords

C PEPTIDE; INSULIN; PROINSULIN; RADIOISOTOPE;

CALORIC RESTRICTION; CASE REPORT; DIAGNOSIS; ENDOCRINE SYSTEM; GLUCOSE BLOOD LEVEL; HISTOLOGY; HYPOGLYCEMIA; INSULINOMA; METHODOLOGY; PLASMA;

ADENOMA, ISLET CELL; ANIMAL; BLOOD GLUCOSE; C-PEPTIDE; FASTING; FISHES; HUMAN; INSULIN; PEPTIDES; PROINSULIN; RADIOIMMUNOASSAY;

EID: 0017605856     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF01236309     Document Type: Article

References (25)

1. Diagnostic tests for functioning pancreatic islet cell tumours
2. Diagnostic tests for evaluating hypoglycaemia
3. Suppression of insulin release by fish insulin induced hypoglycaemia with reference to the diagnosis of insulinomas
4. Diagnosis of insulinomas by suppression tests
5. Prolonged suppression of insulin release by insulin-induced hypoglycaemia demonstration by C-peptide assay
6. Insulin suppression
7. Biochemical and morphological investigations of 30 human insulinomas
8. Circulating proinsulin-like material in patients with functioning insulinomas
9. J. Clin. Endocrinol
10. A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of hormone varieties
11. Radioimmunological determination of human C-peptide in serum
12. Human C-peptide in normal and diabetic subjects
13. Proinsulin secretion by a pancreatic beta-cell adenoma. Proinsulin and C-peptide secretion
14. Biologically active circulating proinsulin-like materials from an islet cell carcinoma patient
15. Circulating proinsulin in patients with islet cell tumours
16. Serum connecting peptide — an indicator of beta cell secretory function
17. Insulinoma with low circulating insulin levels; the diagnostic value of proinsulin measurements
18. Autonomous junction of a pancreatic insulinoma
19. Plasma C-peptide and diagnosis of factitious hyperinsulinism
20. Big Insulin”: a new component of plasma insulin detected by immunoassay
21. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood
22. Familial hyperinsulinaemia: an autosomal dominant defect
23. Increased nerve-growth-stimulating activity in disseminated neurofibromatosis
24. Nerve growth factor and insulin
25. Elevated nonsuppressible insulin-like activity, soluble in acid-ethanol (NSILA-s) in patients with hypoglycaemia and extrapancreatic tumours